Citadel Advisors
TFFP

Citadel Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Citadel Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,579
Closed -$27.3K – 15664
2024
Q3 		$27.3K Buy
+13,579
New +$26.7K ﹤0.01% 12520
2023
Q2 		– Sell
-62
Closed -$891 – 15423
2023
Q1 		$1.05K Sell
62
-1,780
-97% -$38.6K ﹤0.01% 14373
2022
Q4 		$48.4K Sell
1,842
-329
-15% -$15.6K ﹤0.01% 12187
2022
Q3 		$221K Sell
2,171
-237
-10% -$32.1K ﹤0.01% 10213
2022
Q2 		$340K Buy
2,408
+266
+12% +$37.1K ﹤0.01% 9529
2022
Q1 		$338K Sell
2,142
-2,643
-55% -$427K ﹤0.01% 10322
2021
Q4 		$1.06M Buy
4,785
+1,898
+66% +$367K ﹤0.01% 7806
2021
Q3 		$557K Sell
2,887
-754
-21% -$160K ﹤0.01% 9606
2021
Q2 		$875K Sell
3,641
-97
-3% -$26.6K ﹤0.01% 8698
2021
Q1 		$1.27M Buy
3,738
+2,328
+165% +$947K ﹤0.01% 7515
2020
Q4 		$505K Sell
1,410
-1,455
-51% -$560K ﹤0.01% 8130
2020
Q3 		$1.32M Buy
+2,865
New +$809K ﹤0.01% 5517

Other funds holding TFFP

SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Citadel Advisors's TFFP Position: Q4 2024 in Review

Citadel Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 13,579 shares — an estimated $27.3K sold.

Citadel Advisors first reported a position in TFFP in Q3 2020 and held it in 12 quarters. The position peaked at $1.32M in Q3 2020. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.

  • Citadel Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 13,579 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $27.3K.
  • Citadel Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Citadel Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.32M in Q3 2020.
  • 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.